STOCK TITAN

Proposed 10,000-share sale via Merrill Lynch by ARWR (NASDAQ: ARWR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ARWR filed a Form 144 reporting a proposed sale of 10,000 common shares to be sold through Merrill Lynch (75 Rockefeller Plaza). The filing lists an aggregate value of $641,870.05 and a transaction date of 03/05/2026. The notice identifies the sale reason as Compensation with an effective date of 01/05/2025.

The filing also records prior sales: James Hamilton sold 40,164 common shares on 01/05/2026 for $2,534,478.03, listed under "Securities Sold During The Past 3 Months."

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ARWR’s Form 144 disclose about shares to be sold?

It discloses a proposed sale of 10,000 common shares through Merrill Lynch. The filing shows an aggregate value of $641,870.05 with a listing date of 03/05/2026 and a stated reason of Compensation.

Who sold shares recently according to the filing?

James Hamilton sold 40,164 common shares on 01/05/2026. The filing records the sale amount as $2,534,478.03 under "Securities Sold During The Past 3 Months."

Through which broker is the proposed sale being arranged?

The proposed 10,000-share sale is listed with Merrill Lynch at 75 Rockefeller Plaza. The filing names Merrill Lynch as the broker-dealer for the transaction entry.

What reason is given for the 10,000-share sale in the Form 144?

The reason listed is "Compensation." The filing pairs that reason with an effective/entry date of 01/05/2025 in the "Securities To Be Sold" section.

Does the filing show total proceeds or per-share price for the proposed sale?

It shows an aggregate value of $641,870.05 for the 10,000 shares. The document does not provide an explicit per-share price calculation; the aggregate figure is given as shown.
Arrowhead Pharma

NASDAQ:ARWR

View ARWR Stock Overview

ARWR Rankings

ARWR Latest News

ARWR Latest SEC Filings

ARWR Stock Data

7.71B
134.70M
Biotechnology
Pharmaceutical Preparations
Link
United States
PASADENA